Forensic equity & credit research.
Pinpointing catalysts for hidden value accretion and multiple expansion the Street doesn't see
Independent. Not advice.
@anexpertone Because there is a large crowd of people talking about it and are completely disillusioned by the reality of $LIB.V and I want to help those people wake up.
$LIB.V / $VLTLF closed Friday at C$0.54 (US$0.38), down 14% from Monday's pop and 70% below the 52-week high, after three "deals" in eight days and a circular asking for a reverse split of up to 25-for-1. Here's what I see, and what I think the bull crowd keeps missing.
@ValaisValue@chesir3cat@QHCapital@mtack90 Small correction. The Sept 3 term sheet says warrants "equal to up to 10% in respect of the initial US$45 million" facility. I read that as warrant coverage on the loan, ~$4.5M, not 10% of the company. The bigger unknown is the separate "investment commitment." No size given.
@valueventurez@ValaisValue@chesir3cat@QHCapital@mtack90 Zero gets real only if the US raise and Endurance both fail; then Pathfinder's C$15M at 12% sits on everything. Raise size: the release says "an agreed Company investment commitment," no number. For scale, $20โ30M at a 25% discount to US$0.31 is ~35โ52% more shares.
@valueventurez@ValaisValue@chesir3cat@QHCapital@mtack90 Honestly, I'd put a literal zero over the next year low, not none. The Pathfinder note isn't due until Sept 2027, and a company chasing a Nasdaq listing raises before it defaults. The risk I'd underline is the one you named: each raise sells shares cheaper than the last.
@panchofabricio At 22โ26 mg/L and 90/90, the plant makes ~660โ780 t, not 1,000. Much of the cost should scale with barrels, not tonnes, so fewer tonnes means a higher cost per tonne than the $6,206 estimate. A measured grade above ~30 mg/L would make plant one, and the loan, easier to believe.
$LIB.V / $VLTLF: Monday's release pushed Endurance's exclusivity to Jan 15, 2027. The stock fell 20% on 5.7x Friday's TSXV volume to new 52-week lows (C$0.43 / US$0.30). The crowd says "delayed, not cancelled" and blames shorts. The release says otherwise. ๐งต
@panchofabricio Grade decides how many tonnes come out. Freedom 1 is 1,000 t/yr at a design inflow of 120,000 barrels a day (Q2 MD&A). That needs ~27 mg/L of lithium with zero losses, ~33 at 90% recovery and 90% uptime. The June deck assumes ~26 mg/L. No measured grade at the site is published.
@ValaisValue@chesir3cat@QHCapital@mtack90 Agree a proven plant borrows cheaper, but plant two's cheap money needs plant one, and plant one's money needs that raise. Select is paid by royalty; LibertyStream carries the $37.3M. If Select or another strategic writes an equity check near market, I'd change my mind fast.
@ValaisValue@chesir3cat@QHCapital@mtack90 The 11/16 release moved the Endurance deadline to Jan 15 so documents can be "coordinated with the Company's broader capital plan." Funding is still subject to "an agreed Company investment commitment." The lender waits, equity goes first, and it goes first from a 52-week low.
What changes my mind: a signed Endurance agreement with no discounted raise, or a measured brine grade. On the shorts claim: the next short report. What I expect: the raise. Still NO at C$0.44. Saturday's thread with the full arithmetic: https://t.co/HXdrNNiS3o. Not advice.
$LIB.V / $VLTLF closed Friday at C$0.54 (US$0.38), down 14% from Monday's pop and 70% below the 52-week high, after three "deals" in eight days and a circular asking for a reverse split of up to 25-for-1. Here's what I see, and what I think the bull crowd keeps missing.
The loudest bull wrote Monday that this financing "is part of a larger package that includes an IPO" and will likely close after it. Agreed. That's the point. An IPO means new shares sold at a 52-week low, after a split sized to reach $4. Dilution isn't the risk. It's the price.